Effects of Percutaneous Endoscopic Gastrostomy in Patients with Esophageal Squamous Cell Carcinoma During Concurrent Chemoradiotherapy: a Prospective Study
Jie Dong,Zhenbo Dai,Fuliang Cao,Wencheng Zhang,Tian Zhang,Xi Chen,Yajun Chen,Fangdong Zhao,Jiacheng Li,Qingwu Du,Kunning Zhang,Yaqi Zeng,Chunlei Li,Yujie Wang,Yueying Li,Kun Wang,Qingsong Pang
DOI: https://doi.org/10.1016/j.gie.2023.04.2094
IF: 10.396
2023-05-01
Gastrointestinal Endoscopy
Abstract:BACKGROUND AND AIMS: This prospective study aimed to compare the changes in nutritional status and complications among patients with esophageal squamous cell carcinoma(ESCC) who received enteral nutrition through oral intake, percutaneous endoscopic gastrostomy (PEG), and an enteral nasogastric tube (NG) during concurrent chemoradiotherapy (CCRT).METHODS: A total of 141 patients were included: 38, 74, and 29 patients were fed through oral intake, PEG, and NG, respectively. The clinical characteristics and baseline nutritional status of the three groups were recorded and analysed. The patient generated subjective global assessment score, skeletal muscle index, and quality of life were evaluated before and after CCRT; the incidence of adverse events during feeding using PEG and NG was also recorded. The correlations among the different nutritional pathways and the CCRT-related complications (e.g., radiation esophagitis and myelosuppression) were assessed.RESULTS: At baseline, the oral intake group had a significantly better nutritional status and lower disease stage than those in the PEG and NG groups. However, during the CCRT, the oral intake group exhibited the most significant decreases in weight and skeletal muscle index. The synchronous chemotherapy completion rate was the highest in the PEG group. Multivariate analysis showed that the planning tumour volume and the oral intake and NG feeding pathways were associated with ≥grade 2 radiation esophagitis.CONCLUSIONS: We found that PEG effectively maintains the body weight and skeletal muscle index of patients with esophageal cancer during CCRT. It also improves the synchronous chemotherapy completion rate and reduces the occurrence of ≥grade 2 radiation esophagitis.
gastroenterology & hepatology